市場調查報告書
商品編碼
1450925
按產品類型(胰島素幫浦、胰島素幫浦耗材和配件)、配銷通路(醫院藥房、零售藥房、線上銷售、糖尿病診所/中心等)和地區分類的胰島素幫浦市場報告2024-2032Insulin Pumps Market Report by Product Type (Insulin Pumps, Insulin Pump Supplies and Accessories), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales, Diabetes Clinics/ Centers, and Others), and Region 2024-2032 |
2023年全球胰島素幫浦市場規模達53億美元。展望未來, IMARC Group預計到2032年市場規模將達到86億美元,2024-2032年複合年成長率(CAGR)為5.3%。
胰島素幫浦是小型電腦化醫療設備,可以夾在腰帶、口袋或隱藏在衣服下。該幫浦用於根據消費者的基礎和推注率定期在體內輸送受控劑量的胰島素,以控制血糖水平的上升。它透過一根針和一根軟性導管進行操作,用於將胰島素直接插入脂肪組織,然後用膠帶粘住並固定到位。胰島素幫浦透過為 1 型和 2 型糖尿病患者提供食物選擇和飲食計劃的靈活性並減少注射次數來幫助他們。
全球糖尿病盛行率不斷上升以及健康意識不斷提高是市場成長的關鍵因素。經濟現代化顯著增加了多種生活方式疾病的發生,特別是糖尿病。飲食偏好的改變和對含有人工成分和防腐劑的即食包裝食品的依賴進一步加劇了這種情況。由於糖尿病會引發腎衰竭、中風、癱瘓和失明等其他慢性疾病的發生,因此製造商越來越重視創造適應性強且價格實惠的設備。此外,由於高精度血糖感測器和血液監測設備的發展,對高效能胰島素幫浦的需求也有所增加。此外,人均醫療保健服務支出的增加以及改善胰島素幫浦功能的研究和開發的增加等因素也促進了市場的成長。
The global insulin pumps market size reached US$ 5.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 8.6 Billion by 2032, exhibiting a growth rate (CAGR) of 5.3% during 2024-2032.
Insulin pumps are small computerized medical devices that can be clipped on to a belt, pocket or hidden under the clothes. The pump is used to deliver controlled doses of insulin inside the body at regular intervals, depending upon the consumer's basal and bolus rate, to control the rise in blood glucose levels. It operates through a needle and a flexible catheter that is used to insert insulin directly into the fatty tissue, which is then taped and secured in place. Insulin pumps assist individuals suffering from type 1 and type 2 diabetes by providing them flexibility in food options and eating schedules and reduces the number of injection administrations.
The increasing prevalence of diabetes across the globe and rising health awareness are the key factors for market growth. Modernization of economies has significantly enhanced the occurrence of several lifestyle diseases, especially diabetes. This is further augmented by changing dietary preferences and dependency on ready-to-eat packaged food containing artificial ingredients and preservatives. Since diabetes can trigger the occurrence of other chronic conditions such as kidney failure, stroke, paralysis and blindness, manufacturers are increasingly emphasizing on creating adaptive and affordable devices. Additionally, due to the development of highly accurate glucose sensors and blood monitoring devices, the demand for efficient insulin pumps has also increased. Furthermore, factors such as rising per capita expenditure on healthcare services and increasing research and development for improving the functioning of insulin pumps have also contributed to market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global insulin pumps market report, along with forecasts at the global and regional level from 2024-2032. Our report has categorized the market based on product type and distribution channel.
Insulin Pumps
Tethered Pumps
Disposable/Patch Insulin Pumps
Insulin Pump Supplies and Accessories
Infusion Set Insertion Devices
Insulin Reservoirs/Cartridges
Hospital Pharmacy
Retail Pharmacy
Online Sales
Diabetes Clinics/ Centers
Others
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
The report has also analysed the competitive landscape of the market with some of the key players being EOFlow Co. Ltd., Insulet Corp., Medtronic plc, MicroPort Scientific Corporation., Microtech Medical, Roche Diabetes Care Limited, Sooil Development Co. Ltd., Tandem Diabetes Care Inc., Terumo Europe NV (Terumo Corporation), Ypsomed, etc.